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Purpose: This study aimed to characterize and identify the factors affecting fatigue in patients with type
II diabetes mellitus in Korea.
Methods: A total of 180 patients with type II diabetes mellitus were recruited from the outpatient clinic
of a tertiary care hospital. For data collection, a questionnaire survey of diabetes history, hypoglycemia
symptoms, and fatigue was conducted between January and February 2011. Data were analyzed using t
test, analysis of variance, Pearson's correlation, and hierarchical multiple regression.
Results: The mean fatigue and hypoglycemia symptom scores of patients with type II diabetes mellitus
were 2.88 ± 0.61 and 6.18 ± 12.60, respectively. Hypoglycemia symptoms (p ¼ .004), disease duration
(p < .001), and age (p < .001) correlated positively with fatigue. Hierarchical multiple regression analysis
revealed that hypoglycemia symptoms was the variable positively inﬂuencing fatigue in patients with
type II diabetes mellitus after adjustment for inﬂuences of demographic and clinical characteristic
variables.
Conclusions: Hypoglycemia symptoms were conﬁrmed to be a predictor of fatigue. Consequently, it is
essential to consider age, and disease duration as well as hypoglycemia symptoms to intervene fatigue
effectively among patients with type II diabetes mellitus.
Copyright © 2015, Korean Society of Nursing Science. Published by Elsevier. All rights reserved.Introduction
Diabetes has become a global pandemic. According to statistical
data, it is forecasted that the number of patients with diabetes will
increase from 177 million in 2000 to over 360 million by 2030 [1].
This kind of trend has been detected in Korea as well. According to
the Korean National Health and Nutrition Examination Survey
(KNHNES), the prevalence of diabetes in adults aged 30 or older has
increased from 8.6% in 2001 to 10.1% in 2010 [2].
Patients with diabetes suffer from serious health problems that
relate to physical, mental, and social aspects of their lives [3e4].
Fatigue, a common symptom among diabetic patients, may be the
direct result of physiological processes, treatment, and complica-
tions associated with long-term diabetes [3].ment of Nursing, Kyungsung
, South Korea.
ciety of Nursing Science. PublishedAccording to previous studies, up to 60% of patients with dia-
betes experience fatigue symptoms [3,5]. Fatigue has a negative
impact on the activities of daily living. In addition, fatigue impairs a
patient's concentration and leads to frequent mood ﬂuctuations,
which further aggravates their health, increasing the risk of com-
plications and decreasing the quality of life [3e4,6].
Despite the importance of fatigue, many diabetes therapists
often ignore its management and underlying factors [3,7]. There are
several factors associated with fatigue in diabetes patients,
including physiological factors (e.g., hypoglycemia or hyperglyce-
mia) [3,8], psychological factors (e.g., depression and distress
related to the disease) [3,8], epidemiological factors (e.g., age and
educational background) [9], and health-related factors (e.g., ex-
pected disease duration and history of comorbidity) [3e4,7,10].
Hypoglycemia, which is often observed during diabetes treat-
ment, has been suggested by several authors as a particular cause of
fatigue [3,8,11]. The relationship between fatigue and hypoglycemia
symptoms in patients with type II diabetes is still unknown. Bloodby Elsevier. All rights reserved.
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brain, and as the frequency of hypoglycemia symptoms increases,
the cells tend to receive inadequate energy supply [10,11]. However,
previous studies have not established a clear link between fatigue
and hypoglycemia among type II diabetes.
Therefore, the present study aimed to characterize and identify
the explanatory power of hypoglycemia symptoms on fatigue in
patients with type II diabetes in Korea.
Methods
Study design
This is a cross-sectional retrospective correlative study con-
ducted by a questionnaire survey on factors affecting fatigue in
patients with type II diabetes mellitus in Korea.
Samples and procedure
This study conveniently sampled the patients who met the se-
lection criteria attending the outpatient department of a national
university hospital from January 10 to February 11, 2011 for the
treatment of their diabetes. The selection criteria were as follows:
patients with type II diabetes mellitus aged 19 years or older; pa-
tients who had been receiving diabetes treatment for more than 6
months; and those who were aware of the purpose of the research
and agreed to participate. We excluded patients suffering from any
of the following conditions: malignant tumor, acute disease (e.g.,
infection requiring hospitalization or surgery within 3 months),
hypothyroidism, hyperthyroidism, anemia, dementia, mental dis-
ease (e.g., schizophrenia or depressive disorder), stroke, kidney
disease, diabetic neuropathies, proliferative retinopathy, myocar-
dial infarction in the past 3 months, and heart failure.
A total of 218 people participated in the study; however, 180
were ﬁnally chosen and others were excluded due to inadequate
responses. To verify the statistical power of our sample size, we
used the G*power 3.1.7 program [12]. The sample size required in
multiple regression method was 103 with the following parame-
ters: the number of independent variables was 7; power was 80%;
Cronbach's alpha was .05; effect size was 0.15 based on previous
research [8]. The number of participants providing valid data
exceeded 103. Therefore, our sample size seemed appropriate.
To conduct this study, the objectives, methodology, participant
rights, and questionnaire survey were reviewed and approved
(GNUHIRB-2010-081) by the institutional review board. To maintain
consistency in the research method among researchers, a research
director gave them instructions on the survey before data collection.
The interviews were conducted after the researchers were taught
how to collect accurate data. Patients who met the criteria for this
studywere ﬁrst conﬁrmed by a researcher and an inspector from the
digital medical records department of the Division of Endocrinology
in a national university hospital. The objectives and process of the
studywere explained to the target patients verbally and inwriting. If
they agreed to participate in the study, they were asked to give
written informed consent. It took about 10e15 min for each
respondent to ﬁll out the questionnaire forms. Data were collected
anonymously to protect participant rights and privacy. It was agreed
that data would not be used for other purposes. They were also
informed that they could give up on the survey at any time.
Hypoglycemia symptom assessment
Previous studies have revealed a high frequency of hypoglyce-
mia symptoms [13,14]. In this study, hypoglycemia symptoms re-
fers to the frequency of tremor, palpitation, hunger, or sweating inour patients with type II diabetes mellitus anytime during the last
month. A hypoglycemia symptom assessment tool was developed
based on hypoglycemia subscales of the Diabetes Symptom
Checklist-Revised [15]. A preliminary version of this tool was
initially assessed by one endocrinologist and three professors in
adult health nursing. The ﬁnal measurement tool included the
following questions: “Have you experienced tremor, palpitation,
hunger, or sweating in the past month?” and “If you have, how
often did you experience those symptoms?”
Fatigue assessment
Fatigue refers to abnormal exhaustion, lack of stamina to com-
plete a task that requires continued efforts and attention, or a
decrease in physical activity ability [16].
In this study, we used Multidimensional Fatigue Inventory-20
(MFS-20) developed by Smets, Garssen, Bonke, and De Haes [17]
with the consent of the authors. The tool consists of 20 questions
that measure general fatigue, physical fatigue, mental fatigue,
reduced activity, and reduced motivation. A 5-point Likert scale
ranging from 1 (Yes, that is true) to 5 (No, that is not true) was used. A
higher score meant greater fatigue. At the time of development, the
reliability and feasibility of tools were secured in the study by
Smets et al. [17]. Recent studies recommended using total fatigue
summary scores to quantify a patient's fatigue [18]. The fatigue
assessment tool for patients with diabetes was ﬁrst translated into
Korean and later reviewed by a professor who majored in Korean
language and literature. Then, the revised version was read by a
bilingual professor (Korean and English) from the Department of
Nursing, who also compared it to the original English version of
MFS-20. Fatigue scores were assumed to display a normal distri-
bution curve (skewness 0.27, kurtosis 0.06). In terms of reliability,
Cronbach's alpha was .82.
Data analysis
The collected data were analyzed using SPSS version 15.0. The
general characteristics, fatigue, and hypoglycemia of the target
patients were analyzed using frequency, percentage, mean, stan-
dard deviation, and scope. With respect to the assessment of hy-
poglycemia, when the respondents answered “1e2 times” or “2e3
times per month”, the values adopted were 1.5 or 2.5, respectively.
The difference in fatigue by general characteristics was analyzed
using the t test and analysis of variance. The correlations between
fatigue and the variables were analyzed through Pearson's corre-
lation. The fatigue predictor variables were analyzed using hierar-
chical multiple regression.
Results
Fatigue according to participant demographics and clinical
characteristics
Of the 180 participants,118 (65.6%) weremen. The patients were
aged 24e90 years (mean, 58.71 ± 11.01 years). The highest educa-
tion level was junior college or higher (27.8%), followed by
elementary school (26.7%), high school (23.9%), and middle school
(21.7%). Most of the participants lived with their spouse (50.6%)
(Table 1).
The mean duration of diabetes was 142.79 ± 102.91 months
(range, 6e377 months). However, in most of the patients (56.1%),
the disease duration was 10 years or longer. The majority of the
patients (63.3%) also suffered from concomitant diseases other than
diabetes. HbA1c values ranged from 5.50% to 13.2% (M ± SD,
7.24% ± 1.01%) (Table 1).
Table 1 Fatigue according to Participant Demographics and Clinical Characteristics (N ¼ 180).
Variable No. of participants n (%) Fatigue score (M ± SD) F or t p
Gender Male 118 (65.6) 2.79 ± 0.53 2.922 .004
Female 62 (34.4) 3.06 ± 0.70
Age (years)  49a 6 (3.3) 2.68 ± 0.57 6.610 < .0011
50e59b 64 (35.6) 2.70 ± 0.52
60e69c 62 (34.4) 2.94 ± 0.57
 70d 32 (17.8) 3.22 ± 0.71
Education level Primary school 48 (26.7) 3.04 ± 0.72 5.279 .002
Middle school 39 (21.7) 3.03 ± 0.59
High school 43 (23.9) 2.87 ± 0.53
 College 50 (27.8) 2.61 ± 0.48
Family type Alone 16 (8.9) 2.90 ± 0.50 0.848 .469
With spouse 91 (50.6) 2.94 ± 0.56
With children 64 (35.6) 2.78 ± 0.68
With others 9 (5.0) 2.93 ± 0.73
Duration of disease (years) <1a 6 (3.3) 2.62 ± 0.25 5.533 .0012
1 <5b 40 (22.2) 2.66 ± 0.65
5 <10c 33 (18.3) 2.70 ± 0.56
10d 101 (56.1) 3.03 ± 0.58
Treatment type Insulin 58 (37.8) 3.09 ± 0.60 3.242 .001
Noninsulin 112 (62.2) 2.78 ± 0.59
Other diseasese No 66 (36.7) 3.09 ± 0.58 3.586 <.001
Yes 114 (63.3) 2.76 ± 0.60
HbA1c (%) < 7 80 (44.4) 2.92 ± 0.68 0.783 .435
 7 100 (55.6) 2.84 ± 0.55
Note. 1 ¼ a,b<d; 2 ¼ b<d; e Except those mentioned in the exclusion criteria.
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(p ¼ .004), age (p < .001), educational background (p ¼ .002), ex-
pected disease duration (p¼ .001), type of treatment (p¼ .001), and
the existence of other diseases (p < .001) (Table 1).
Fatigue and hypoglycemia symptom in patients with type II diabetes
mellitus
The participants had mean fatigue and hypoglycemia symptom
scores of 2.88± 0.61 and 6.18 ± 12.60, respectively. On average, they
experienced hypoglycemia symptoms 6e7 times per month.
Factors correlating with fatigue in patients with type II diabetes
mellitus
A signiﬁcant correlation was observed between fatigue and age
(r ¼ .34, p < .001), expected disease duration (r ¼ .37, p < .001), and
hypoglycemia symptoms (r ¼ .22, p ¼ .004) (Table 2). In other
words, fatigue increased as age, duration of disease, and hypogly-
cemic symptom frequency increased.
Factors affecting fatigue in patients with type II diabetes mellitus
To identify the variables affecting fatigue in patients with type II
diabetes mellitus, hierarchical regression analysis was performed.
The variables measured on a nominal scale were converted to
dummy variables. The independent variables used in regression
analysis were gender (male ¼ 0, female ¼ 1), educational back-
ground, type of treatment (noninsulin ¼ 0, insulin ¼ 1), and exis-
tence of other diseases (no ¼ 0, yes ¼ 1), all of which had showed aTable 2 Correlations between Fatigue and Age, Duration of Disease, and Hypoglycemia
Symptoms.
Variable Age Duration of disease Hypoglycemia symptoms
r p r p r p
Fatigue .34 < .001 .37 < .001 .22 .004statistically signiﬁcant difference in terms of fatigue. They also
included expected disease duration, age, and hypoglycemia
symptoms, which were correlated with fatigue according to Pear-
son's correlation. The DurbineWatson test score was 1.998 with no
correlations among residuals. The tolerance ranged from 0.70 to
0.96 (> 0.10) and the variance inﬂation factor ranged from 1.04 to
1.42 (< 10), which showed that no variables exhibited multi-
collinearity. Therefore, it appeared that a regression model would
be appropriate. In the analysis of fatigue, only age, entered in step 1,
emerged as a signiﬁcant predictor of fatigue. In step 2, three clinical
characteristics were entered. Age and duration of disease accoun-
ted for 24% of the variance observed for fatigue (F¼ 10.33, p < .001).
Finally, when hypoglycemia symptoms were entered in the last
step, age, duration of disease, and hypoglycemia symptoms were
signiﬁcant predictors of fatigue. The variables in step 3 contribute
to fatigue 3% more than the variables in step 2 do. The total
explanatory adequacy of these factors was 27% (F ¼ 10.39, p < .001)
(Table 3).
Discussion
Recently, the number of patients with type II diabetes mellitus
in Korea has been increasing, and fatigue has been the most typical
symptom they suffer from. However, studies on fatigue experi-
enced by patients with type II diabetes mellitus are scarce. There-
fore, this study is meaningful in that it investigated fatigue and its
inﬂuential factors in patients with type II diabetesmellitus in Korea.
Our ﬁndings provide a better understanding of fatigue and estab-
lish basic data for nursing intervention.
In this study, the participants scored 2.88 out of 5 points for
fatigue, which is lower than that reported by Fritschi [8] (3.19 out of
5) but higher than that reported by Weijman et al. [19] (2.28 out of
5) in the diabetic patients. Young people and women tend to
experience fatigue more often [20]. Therefore, it is reasonable that
the values found by Fritschi [8] are higher than those found in this
study, because the participants of the former study were female
diabetic patients aged 40e65 years. Studies were conducted
outside Korea; therefore, they were not compared owing to dif-
ferences in the genetic and cultural backgrounds. However, in our
Table 3 Variables Predicting Fatigue in Patients with Type 2 Diabetes Mellitus.
Steps Variable b t p
Step 1 (Constant) 6.62 <.001
Gendera .13 1.68 .095
Age .29 4.04 <.001
Education level e.13 1.67 .096
Adjusted R2 ¼ .15, F ¼ 11.28, and p < 0.001
Step 2 (Constant) 6.62 <.001
Gender .14 1.89 .061
Age .22 3.04 .003
Education level e.10 1.30 .194
Duration of disease .21 2.73 .007
Treatment typeb .11 1.54 .125
Other diseasesc e.13 1.83 .070
Adjusted R2 ¼ .24, F ¼ 10.33, and p < .001
Step 3 (Constant) 5.85 <.001
Gender .14 1.93 .055
Age .24 3.44 .001
Education level e.08 1.05 .294
Duration of disease .20 2.73 .007
Treatment type .09 1.31 .192
Other diseases e.11 1.65 .101
Hypoglycemia symptoms .19 2.86 .005
Adjusted R2 ¼ .27, F ¼ 10.39, and p < .001
a Dummy code, where male is 0, female is 1;
b Dummy code where noninsulin is 0, insulin is 1;
c Dummy code where no is 0, yes is 1.
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2 diabetes in Korea. An additional investigation on the degree of
fatigue by characteristic resulted in the following order: physical
fatigue 3.20, reduced activity 3.03, general fatigue 2.96, reduced
motivation 2.9, andmental fatigue 2.48. Therefore, it is necessary to
fully consider the ﬁndings from this study in order to develop a
fatigue intervention program for patients with type II diabetes.
However, in order to generalize the ﬁndings, duplicate follow-up
studies are required for conﬁrmation.
In this study, fatigue was signiﬁcantly higher among female
patients, older aged, those with longer expected disease duration,
those treated with insulin, and those who were suffering from
other diseases. This is in agreement with studies reporting that
fatigue is more severe in female patients [21], elderly patients [9],
and thosewho suffer from concurrent chronic diseases [22]. Fatigue
was also found to be more severe in those with a lower educational
background [9,23]. However, our results are contradictory to
studies suggesting that fatigue is more severe in male patients [23]
and in those with a higher educational background [20], as well as
contradictory to studies reporting that the expected disease dura-
tion and age are unrelated to fatigue [24]. However, studies on
patients with type II diabetes mellitus are limited, and comparisons
were made against participants with different medical conditions.
Therefore, further conﬁrmatory studies are needed.
The hierarchical multiple regression analysis performed to
identify factors that inﬂuence fatigue in patients with type II dia-
betes mellitus revealed that hypoglycemia symptoms was the sig-
niﬁcant inﬂuencing variables of fatigue, even after controlling for
age and duration of illness. Because of lack of comparable previous
studies, no direct comparisons can be made of the signiﬁcance of
explanatory power. However, there were several studies on corre-
lation of the hypoglycemia symptoms and fatigue. King et al. [11]
reported that nocturnal hypoglycemia among patients with
insulin-dependent diabetes mellitus was related with chronic fa-
tigue on the day after the hypoglycemia episode. In their study,
participants experienced hypoglycemia symptoms about 6 times
per month. Leiter et al. [25] reported that respondents experience
hypoglycemia symptoms about 5.5 times per month. Although,
they studied the correlation, they did not mention the inﬂuence ofthese factors on fatigue. In our study, we conﬁrmed the inﬂuence of
hypoglycemia symptoms, age, and disease duration on fatigue as
well as correlation. This is noteworthy. Meanwhile, despite the
ﬁnding in this study that hypoglycemia symptoms are a factor that
signiﬁcantly inﬂuences fatigue, the treatment type did not show a
signiﬁcant inﬂuence event though hypoglycemia symptoms were
the most common problem experienced by diabetic patients un-
dergoing insulin therapy. Such ﬁndings are thought to be attributed
to the lack of signiﬁcant differences in hypoglycemia symptoms
regarding the treatment type, which is viewed as a result of the
self-reported research method of measuring hypoglycemia symp-
toms. Hypoglycemia was conﬁrmed by Whipple's triad (i.e., hypo-
glycemia symptoms, a low plasma glucose concentration, and relief
of those symptoms when the plasma glucose concentration is
raised) [26]. Therefore, it is necessary to check these physiological
indexes. Although this is a questionnaire-based retrospective sur-
vey, self-reported data collection is still the most feasible approach
considering the fact that most patients with type II diabetes mel-
litus do not self-monitor blood glucose levels. In fact, in these pa-
tients, a previous experience of a hypoglycemia symptom is a
signiﬁcant predictor of the incidence of hypoglycemia [27]. If the
frequency of hypoglycemia increases, the patients may not be able
to detect its symptoms [14], which may further cause signiﬁcant
morbidity [27]. Hypoglycemia symptoms can be exacerbated
through patients' ineffective disease management, adverse side
effects of medication, and the consequences of complications; thus,
it is a variable that can be controlled through effective self-
management [28]. Therefore, the signiﬁcance of the current study
lies in considering hypoglycemia symptomsdas a controllable
variabledto be one of the variables explaining fatigue in diabetes
patients and determining that it is an inﬂuencing variable with an
explanatory power of 3%. Therefore, health management experts of
type II diabetes mellitus should make continuous efforts to control
hypoglycemia, to reduce fatigue.
This study has several limitations. First, we did not include other
inﬂuential factors such as psychological factors, and distress related
to the disease. Second, this is a cross-sectional retrospective study
performed at a single institution. Third, we did not study the
characteristics such as frequency, triggers, and aggravating factors
of fatigue in patients with type II diabetes; therefore, the general-
ization of the results could be limited. Hence, further longitudinal
prospective, multicenter studies are needed to overcome these
limitations. Despite these limitations, this is the ﬁrst study to
address inﬂuence of hypoglycemia symptoms on fatigue in patients
with type II diabetes mellitus.Conclusion
The study ﬁndings are signiﬁcant because we investigated fa-
tigue in relation with type II diabetes mellitus and performed hi-
erarchical regression analysis by including hypoglycemia
symptoms as a factor associated with fatigue. The hierarchical
multiple regression analysis ﬁndings revealed the inﬂuence of hy-
poglycemia symptoms on fatigue.
Therefore, in the clinical setting, the diabetic health care pro-
vider should consider hypoglycemia symptoms more seriously in
patients with type II diabetes mellitus in order to reduce their fa-
tigue. In addition, our data suggests including hypoglycemia
symptoms, age, and disease duration in educational program
development to relieve fatigue in patients with diabetes.Conﬂict of interest
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